The number of APC mutations we observed here was slightly lower than estimates from the TCGA, who report frequencies of 60–80% for hypermutated and non‐hypermutated cancers, respectively, and probably reflects the difficulties of identifying somatic mutations in lesions with low tumour cellularity. The gene discussed is APC; the disease is neoplasm.